Delivery Order SPE2DB22D2206-SPE2DB25FHK99

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $6,111.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp also holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,977.80 delivery order contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,762.46 firm-fixed-price delivery order is for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used in the treatment of respiratory conditions. The contract has a period of performance through May 29, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $3,566.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on May 1, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
This is a $31,988.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE-SALMETEROL 230-21 12GM. The contract has an ultimate completion date of June 4, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.97 firm fixed price delivery order is for the supply of FLUTICASONE-SALMETEROL 115-21 12GM, a medication, with a completion date of June 12, 2025. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.61 Firm Fixed Price delivery order is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,598.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,516.15 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHK99
    Delivery Order

This is a $3,647.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through June 16, 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract award does not have a set-aside designation, indicating open competition. As a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems, Amerisourcebergen Drug Corp fulfills diverse pharmaceutical and medical supply requirements through its DLA contracts.

Generated 9/12/25, 10:47 AM